HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Daniel Mendoza Selected Research

Daniel Mendoza Research Topics

Disease

6Neoplasms (Cancer)
03/2019 - 10/2016
3Glioma (Gliomas)
03/2018 - 10/2016
2Viremia
03/2014 - 05/2012
2Infections
02/2013 - 02/2011
1Colorectal Neoplasms (Colorectal Cancer)
03/2018
1Glioblastoma (Glioblastoma Multiforme)
10/2016
1Inflammation (Inflammations)
03/2014
1HIV Infections (HIV Infection)
02/2013
1Persistent Infection
02/2011
1Rheumatoid Arthritis
06/2009
1Silicosis
07/2008
1Multiple Organ Failure (MODS)
10/2004

Drug/Important Bio-Agent (IBA)

3Flucytosine (Ancobon)FDA Link
03/2018 - 10/2016
3vocimagene amiretrorepvecIBA
03/2018 - 10/2016
3Fluorouracil (Carac)FDA LinkGeneric
03/2018 - 10/2016
2Cytosine DeaminaseIBA
03/2018 - 10/2016
2DNA (Deoxyribonucleic Acid)IBA
01/2018 - 05/2012
2VaccinesIBA
02/2013 - 02/2011
1Monoclonal AntibodiesIBA
03/2019
1cyclopropapyrroloindoleIBA
03/2019
1Proteins (Proteins, Gene)FDA Link
01/2018
1Peptides (Polypeptides)IBA
01/2018
1ProdrugsIBA
07/2017
1Lomustine (CCNU)FDA Link
10/2016
1RNA (Ribonucleic Acid)IBA
03/2014
1Biomarkers (Surrogate Marker)IBA
03/2014
1fibrin fragment D (D-dimer)IBA
03/2014
1Thromboplastin (Tissue Factor)IBA
03/2014
1Granzymes (Granzyme)IBA
02/2013
1AIDS VaccinesIBA
02/2011
1Anesthetics (Anesthetic Agents)IBA
06/2009
1Silicon Dioxide (Silica)FDA LinkGeneric
07/2008
1Rifampin (Rifampicin)FDA LinkGeneric
10/2004
1resazurinIBA
10/2004
1Isoniazid (Ftivazide)FDA LinkGeneric
10/2004

Therapy/Procedure

1Aftercare (After-Treatment)
10/2016
1Art Therapy
03/2014